Close Menu

Q Lu

Relationship between Clinical Systemic Lupus Erythematosus Symptoms and Indexes of Blood, Renal Function, Liver Function and Immunology

DOI: 
10.7727/wimj.2017.148
Synopsis: 
To study the relationships between clinical SLE symptoms and indexes of blood, renal function, liver function and immunology. The present study indicated that some biochemical, including RBC, Hb, BUN, albuminuria and cylindruria, liver damage, AST, TG, SSA, AnuA and u1RNP, are closely to the prognosis of SLE, and it’s important to control these biochemical indexes during the treatment period.

ABSTRACT

 

Objective: This paper aimed to study the relationships between clinical systemic lupus erythematosus (SLE) symptoms and indexes of blood, renal function, liver function and immunology.

Accepted: 
12 Dec, 2017
PDF Attachment: 
Journal Sections: 
e-Published: 14 Dec, 2017

Disclaimer

Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

The Application Methods of MAPKs Signal Pathway Inhibitor SP600125 and SB203580 in Long-term In-vivo Experiments

Issue: 
DOI: 
10.7727/wimj.2015.487
Pages: 
98-104
Synopsis: 
The intravenous injection of mitogen-activated protein kinase inhibitors SP600125 and SB203580 for four weeks significantly reduced the phosphorylation levels of JNK and p38 in vivo.

ABSTRACT

Objective: To explore the application methods of MAPK signal pathway inhibitor SP600125 and SB203580’s long-term experiments in vivo.

Accepted: 
30 Sep, 2015
PDF Attachment: 
Journal Sections: 
e-Published: 15 Jan, 2016
Subscribe to RSS - Q Lu
Top of Page